Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ETSEGENET T AYELE

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1588752778
CMS profile
116933
Location
LOS ALAMITOS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$519.41

28 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $519.41 28

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 1; records 1–28 of 28 matching records. This page contains 28 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ETSEGENET T AYELE

NPI 1588752778 · CMS profile ID 116933

Allopathic & Osteopathic Physicians / Internal Medicine

LOS ALAMITOS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–28 of 28 matching records. This page contains 28 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588752778?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ETSEGENET T AYELE, NPI 1588752778, CMS profile ID 116933. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–28 of 28 matching records. This page contains 28 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588752778?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ETSEGENET T AYELE, NPI 1588752778, CMS profile ID 116933. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–28 of 28 matching records. This page contains 28 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588752778?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ETSEGENET T AYELE, NPI 1588752778, CMS profile ID 116933, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–28 of 28 matching records. This page contains 28 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1588752778?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

28 matching records · $519.41 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 28 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–28 of 28.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Vanda Pharmaceuticals Inc. $5.3512/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956519 CMS
Vanda Pharmaceuticals Inc. $30.1912/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956517 CMS
Vanda Pharmaceuticals Inc. $5.1711/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956515 CMS
UROVANT SCIENCES INC $19.9711/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 931045363 CMS
Vanda Pharmaceuticals Inc. $5.9311/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956513 CMS
INTRA-SANA LABORATORIES $19.1111/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964115621 CMS
Vanda Pharmaceuticals Inc. $4.6310/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956511 CMS
Lilly USA, LLC $34.0110/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918046021 CMS
Vanda Pharmaceuticals Inc. $5.1210/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956509 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.4010/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959484591 CMS
Vanda Pharmaceuticals Inc. $5.6609/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956507 CMS
Vanda Pharmaceuticals Inc. $17.1509/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956505 CMS
Vanda Pharmaceuticals Inc. $5.6208/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956503 CMS
Xeris Pharmaceuticals, Inc. $23.8008/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946475983 CMS
Lilly USA, LLC $30.8708/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918031763 CMS
NuVasive, Inc. $34.3408/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948902657 CMS
Novartis Pharmaceuticals Corporation $23.4607/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893511555 CMS
Vanda Pharmaceuticals Inc. $31.6507/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956501 CMS
Vanda Pharmaceuticals Inc. $30.2306/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956499 CMS
Vanda Pharmaceuticals Inc. $4.5906/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956497 CMS
Neurocrine Biosciences, Inc. $28.6105/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963237565 CMS
Vanda Pharmaceuticals Inc. $34.2905/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956495 CMS
Vanda Pharmaceuticals Inc. $4.8804/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956493 CMS
ABBVIE INC. $13.3904/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890540849 CMS
Horizon Therapeutics plc $18.5903/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937588833 CMS
Vanda Pharmaceuticals Inc. $27.1303/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956489 CMS
Vanda Pharmaceuticals Inc. $16.3102/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951956487 CMS
Biohaven Pharmaceutical Holding Company Ltd. $15.9601/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923531161 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $368.35 19
PY2020 $317.46 15
PY2021 $463.99 22
PY2022 $519.41 28
PY2023 $854.50 45
PY2024 $3,007.69 39
PY2025 $916.31 42

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $360,731.35 15
PY2024 Recipient $6,917.95 2
PY2024 Principal investigator $224,529.93 19
PY2023 Recipient $730.01 1
PY2023 Principal investigator $155,662.45 239
PY2022 Recipient $2,311.84 12
PY2022 Principal investigator $87,836.25 102
PY2021 Principal investigator $177,471.01 498
PY2020 Principal investigator $80,548.24 275
PY2019 Principal investigator $130,163.71 83

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $22,862.79 12/31/2024 Non-covered Recipient Entity
Pacific Clinical Studies
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression No dispute reported 06/30/2026 1136418770
Principal investigator 1 Novo Nordisk AS $4,950.00 12/02/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096734065
Principal investigator 1 Novo Nordisk AS $1,221.70 11/20/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096815581
Recipient Eli Lilly and Company $23.95 10/08/2024 Covered Recipient Physician A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137347224
Recipient Eli Lilly and Company $6,894.00 09/24/2024 Covered Recipient Physician A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137347276
Principal investigator 1 Novo Nordisk AS $4,110.91 09/20/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096821405
Principal investigator 1 Novo Nordisk AS $6,169.14 08/23/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096822201
Principal investigator 1 Novo Nordisk AS $5,234.83 07/22/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096800944
Principal investigator 1 Novo Nordisk AS $357.23 06/21/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096793497
Principal investigator 1 AstraZeneca Pharmaceuticals LP $44,465.70 06/14/2024 Non-covered Recipient Entity
ASCADA HEALTH, PC
a phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd progression in participants with ckd and high blood pressure No dispute reported 06/30/2026 1110846045
Principal investigator 1 Novo Nordisk AS $2,043.07 05/29/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096738591
Principal investigator 1 Novo Nordisk AS $1,786.14 04/30/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096864645
Principal investigator 1 Novo Nordisk AS $431.73 04/02/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096749955
Principal investigator 1 Novo Nordisk AS $130.86 04/02/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096834635
Principal investigator 1 Novo Nordisk AS $2,213.60 03/27/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096738708
Principal investigator 1 Eli Lilly and Company $349.02 03/18/2024 Non-covered Recipient Entity
PACIFIC CLINICAL STUDIES INC
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137363637
Principal investigator 1 Novo Nordisk AS $2,857.82 02/29/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096739057
Principal investigator 1 Eli Lilly and Company $2,390.85 01/31/2024 Non-covered Recipient Entity
TRIAL CONCIERGE
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137368338
Principal investigator 1 Novo Nordisk AS $2,470.54 01/24/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096833390
Principal investigator 1 Eli Lilly and Company $120,409.00 01/09/2024 Non-covered Recipient Entity
PACIFIC CLINICAL STUDIES INC
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137364981
Principal investigator 1 Novo Nordisk AS $75.00 01/08/2024 Non-covered Recipient Entity
EASTERN NEPHROLOGY ASSOCIATES
EX9924-4473 No dispute reported 06/30/2026 1096811510